Follow-The-Filings

Security · featured owners

XRAY Dentsply Sirona Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 4 Owners
  • Max 12.2%
  • $120M
  • 2 add 2 reduce

XRAY (Dentsply Sirona Inc.) is held in 4 featured 13F books as of 2026 Q2. Alex Roepers - Atlantic Investment Management is the largest tracked holder by portfolio weight (12.2%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 12.2% (Alex Roepers - Atlantic Investment Management) · not free-float ownership

  1. Alex Roepers add 12.2%
  2. John Rogers add 0.85%
  3. First Eagle Investment Manage... reduce 0.02%
  4. Cathie Wood reduce 0.02%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
John Rogers - Ariel Investments 2026 Q2 0.85% Add +25.7% 8,026,107 $85M history
Alex Roepers - Atlantic Investment Management 2026 Q2 12.2% Add +261.1% 2,203,000 $23M history
First Eagle Investment Management 2026 Q2 0.02% Reduce −94.4% 851,347 $9M history
Cathie Wood - Ark Investment Management 2026 Q2 0.02% Reduce −11.7% 235,538 $2M history

4 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 8 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K/A 2.02,9.01 Filing Doc
8-K 9.01 Filing Doc
10-Q Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 13 rows shown

Filed Form Detail Links
4 Period Aug 10, 2026 Filing Doc
4 Period Aug 7, 2026 Filing Doc
4 Period Jun 30, 2026 Filing Doc
4/A Period Jun 12, 2026 Filing Doc
4 Period Jun 15, 2026 Filing Doc
4 Period Jun 11, 2026 · 2 forms Filing Doc
4 Period Jun 12, 2026 Filing Doc
4 Period Jun 15, 2026 Filing Doc
4 Period Jun 12, 2026 Filing Doc
4 Period Jun 3, 2026 · 11 forms Filing Doc
4 Period May 22, 2026 Filing Doc
4 Period Mar 31, 2026 Filing Doc
4 Period Mar 11, 2026 · 2 forms Filing Doc

Updated 3 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $3.96B $3.79B $3.68B
Gross profit $2.09B $1.96B $1.84B
Gross margin * 52.6% 51.6% 50.0%
Net income -$132M -$910M -$598M
Net margin * -3.3% -24.0% -16.3%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $1.97B $1.75B $2.02B
Total non-current assets * $5.4B $4.01B $3.41B
Total assets $7.37B $5.75B $5.43B
Total current liabilities $1.42B $1.59B $1.34B
Total non-current liabilities * $2.65B $2.22B $2.75B
Total equity $3.29B $1.94B $1.34B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $377M $461M $235M
Cash from investing -$89M -$197M -$132M
Cash from financing -$307M -$302M -$80M
Net change in cash -$31M -$62M $54M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders